News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
453,748 Results
Type
Article (23264)
Company Profile (154)
Press Release (430330)
Multimedia
Podcasts (77)
Webinars (11)
Section
Business (143450)
Career Advice (1307)
Deals (25688)
Drug Delivery (104)
Drug Development (54159)
Employer Resources (90)
FDA (9939)
Job Trends (10999)
News (239375)
Policy (23044)
Tag
2024 BioCapital Digital (9)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (5)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (2)
2025 BioForest Digital (4)
2025 Lone Star Bio Digital (4)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (1365)
Accelerated approval (3)
Adcomms (21)
Allergies (55)
Alliances (38545)
ALS (57)
Alzheimer's disease (793)
Antibody-drug conjugate (ADC) (100)
Approvals (9947)
Artificial intelligence (194)
Autoimmune disease (16)
Automation (9)
Bankruptcy (235)
Best Places to Work (8430)
BIOSECURE Act (17)
Biosimilars (102)
Biotechnology (69)
Bladder cancer (47)
Brain cancer (20)
Breast cancer (154)
Cancer (1385)
Cardiovascular disease (137)
Career advice (1074)
Career pathing (23)
CAR-T (65)
Cell therapy (214)
Cervical cancer (11)
Clinical research (45202)
Collaboration (605)
Compensation (352)
Complete response letters (23)
COVID-19 (1499)
CRISPR (29)
C-suite (182)
Cystic fibrosis (61)
Data (1392)
Decentralized trials (2)
Denatured (20)
Depression (30)
Diabetes (164)
Diagnostics (4092)
Digital health (11)
Diversity (9)
Diversity, equity & inclusion (23)
Drug discovery (91)
Drug pricing (119)
Drug shortages (31)
Duchenne muscular dystrophy (63)
Earnings (52914)
Editorial (37)
Employer branding (10)
Employer resources (82)
Events (63815)
Executive appointments (575)
FDA (10751)
Featured Employer (27)
Friedreich's ataxia (3)
Frontotemporal dementia (1)
Funding (430)
Gene editing (60)
Generative AI (20)
Gene therapy (180)
GLP-1 (637)
Government (3283)
Grass and pollen (5)
Guidances (40)
Healthcare (11986)
Huntington's disease (13)
IgA nephropathy (21)
Immunology and inflammation (93)
Indications (22)
Infectious disease (1609)
Inflammatory bowel disease (93)
Inflation Reduction Act (8)
Influenza (38)
Intellectual property (69)
Interviews (194)
IPO (10593)
IRA (47)
Job creations (2858)
Job search strategy (940)
Kidney cancer (7)
Labor market (27)
Layoffs (324)
Leadership (17)
Legal (5285)
Liver cancer (37)
Lung cancer (199)
Lymphoma (106)
Machine learning (3)
Management (34)
Manufacturing (266)
MASH (53)
Medical device (6176)
Medtech (6179)
Mergers & acquisitions (15499)
Metabolic disorders (545)
Multiple sclerosis (57)
NASH (20)
Neurodegenerative disease (56)
Neuropsychiatric disorders (24)
Neuroscience (1154)
NextGen: Class of 2025 (4488)
Non-profit (2795)
Northern California (1439)
Now hiring (23)
Obesity (331)
Opinion (207)
Ovarian cancer (41)
Pain (74)
Pancreatic cancer (49)
Parkinson's disease (94)
Partnered (17)
Patents (166)
Patient recruitment (59)
Peanut (23)
People (44000)
Pharmaceutical (77)
Pharmacy benefit managers (21)
Phase I (14064)
Phase II (19292)
Phase III (15305)
Pipeline (930)
Policy (152)
Postmarket research (1733)
Preclinical (5060)
Press Release (70)
Prostate cancer (77)
Psychedelics (23)
Radiopharmaceuticals (183)
Rare diseases (272)
Real estate (4724)
Recruiting (34)
Regulatory (16024)
Reports (23)
Research institute (1269)
Resumes & cover letters (207)
Rett syndrome (1)
RNA editing (2)
RSV (29)
Schizophrenia (65)
Series A (65)
Series B (41)
Service/supplier (17)
Sickle cell disease (42)
Southern California (1362)
Special edition (16)
Spinal muscular atrophy (117)
Sponsored (21)
Startups (2435)
State (2)
Stomach cancer (9)
Supply chain (65)
Tariffs (45)
The Weekly (55)
United States (14027)
Vaccines (352)
Venture capitalists (30)
Weight loss (253)
Women's health (21)
Worklife (11)
Date
Today (104)
Last 7 days (509)
Last 30 days (1630)
Last 365 days (21428)
2025 (6953)
2024 (22799)
2023 (25785)
2022 (34443)
2021 (36716)
2020 (36531)
2019 (32853)
2018 (25150)
2017 (22468)
2016 (21443)
2015 (24716)
2014 (19159)
2013 (16203)
2012 (17502)
2011 (18139)
2010 (16560)
Location
Africa (531)
Alabama (31)
Alaska (5)
Arizona (111)
Arkansas (10)
Asia (29581)
Australia (3910)
California (3418)
Canada (1548)
China (383)
Colorado (176)
Connecticut (163)
Delaware (100)
Europe (63313)
Florida (577)
Georgia (94)
Hawaii (1)
Idaho (32)
Illinois (398)
India (23)
Indiana (228)
Iowa (5)
Japan (134)
Kansas (77)
Kentucky (21)
Louisiana (7)
Maine (27)
Maryland (609)
Massachusetts (2692)
Michigan (116)
Minnesota (198)
Mississippi (2)
Missouri (47)
Montana (18)
Nebraska (16)
Nevada (35)
New Hampshire (28)
New Jersey (1295)
New Mexico (24)
New York (963)
North Carolina (713)
North Dakota (5)
Northern California (1439)
Ohio (146)
Oklahoma (10)
Oregon (24)
Pennsylvania (873)
Puerto Rico (12)
Rhode Island (23)
South America (792)
South Carolina (5)
Southern California (1362)
Tennessee (70)
Texas (515)
Utah (83)
Virginia (114)
Washington D.C. (56)
Washington State (297)
West Virginia (3)
Wisconsin (38)
453,748 Results for "pci pharma services lsne".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PCI Pharma Services to Acquire US-based Aseptic Fill-Finish CDMO Ajinomoto Althea
April 24, 2025
·
3 min read
Deals
PCI Pharma Services Announces the Closing of Its Acquisition of LSNE
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), today announced the closing of the previously announced acquisition of Lyophilization Services of New England, Inc. (LSNE), a premier contract development and manufacturing organization headquartered in Bedford, New Hampshire.
December 14, 2021
·
2 min read
Pharm Country
Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases
Aldena Therapeutics has chosen PCI Pharma Services, a world-leading global contract development and manufacturing organization to formulate, package, and distribute ALD-102, an siRNA-based investigational injectable treatment for inflammatory dermatological conditions, all under one roof at PCI’s San Diego facility.
October 19, 2023
·
4 min read
Press Releases
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
September 24, 2024
·
5 min read
Press Releases
PCI Biotech full year 2024 interim results
February 27, 2025
·
4 min read
Press Releases
PCI Biotech: Invitation to preliminary full-year 2024 results presentation
February 25, 2025
·
1 min read
Deals
PCI Pharma Services Announces the Acquisition of LSNE to Add End-To-End Global Sterile Fill-Finish and Lyophilization Manufacturing Capabilities
PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global integrated solutions provider, announced it has signed a definitive agreement to acquire Lyophilization Services of New England, Inc. (LSNE), a premier contract development and manufacturing organization (CDMO) headquartered in Bedford, New Hampshire, from global private equity firm Permira.
October 12, 2021
·
3 min read
Government
Trump Tariffs Miss Pharma For Now, But Uncertainties Loom
Pharma’s reprieve from Donald Trump’s tariffs is expected to be temporary, with Leerink analysts anticipating possible sector-specific duties “in the next month or so.”
April 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Precision Medicine Group Names Pharma Services Innovator, Eric Hodgins, as Chief Information and Technology Officer
April 16, 2025
·
3 min read
Compensation
Top 6 Highest-Paid Pharma CEOs in 2024
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
April 16, 2025
·
7 min read
·
Annalee Armstrong
1 of 45,375
Next
